- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Financially Fit Penny Stocks
Global Pharmaceuticals & Biotech Financially Fit Penny Stocks
Results
452
A Penny Stocks screener, typically smaller or younger companies trading at a price below 5, with a focus on solid financial health that should present companies with a lower risk profile than other early-stage businesses
452 companies
Willow Biosciences
Market Cap: CA$5.8m
A biotechnology company, develops, produces, and sells plant derived ingredients for consumer care, food and beverage, and pharmaceutical products in the United States.
WLLW
CA$0.035
7D
0%
1Y
-65.0%
Telomir Pharmaceuticals
Market Cap: US$136.3m
A pre-clinical stage biopharmaceutical company, focuses on developing pharmaceutical products for reversal of oxidative stress, cellular protection, and regulatory mechanism.
TELO
US$4.17
7D
-1.4%
1Y
-13.7%
Simply Solventless Concentrates
Market Cap: CA$73.5m
Simply Solventless Concentrates Ltd. cultivates, processes, formulates, manufactures, and sells a portfolio of terpene-rich solventless concentrates for the recreational, medical, and business to business cannabis markets in Canada.
HASH
CA$0.70
7D
16.7%
1Y
324.2%
Grey Wolf Animal Health
Market Cap: CA$37.6m
Operates as an animal health and wellness company in Canada.
WOLF
CA$1.06
7D
-0.9%
1Y
29.3%
Tiansheng Pharmaceutical Group
Market Cap: CN¥1.4b
Engages in the pharmaceutical manufacturing and circulation activities.
002872
CN¥4.26
7D
8.4%
1Y
-11.4%
Medicure
Market Cap: CA$9.3m
A biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States.
MPH
CA$0.89
7D
18.7%
1Y
-22.6%
Adastra Holdings
Market Cap: CA$2.2m
Adastra Holdings Ltd. extracts and processes cannabis for recreational and medical markets in Canada.
XTRX
CA$0.39
7D
-7.1%
1Y
-84.1%
Hunan Er-Kang Pharmaceutical
Market Cap: CN¥5.8b
Manufactures and sells APIs, finished drug products, and pharmaceutical excipients in China and internationally.
300267
CN¥2.83
7D
2.5%
1Y
6.8%
3D Medicines
Market Cap: HK$1.0b
A biopharmaceutical company, researches, develops, and commercializes oncology products and other drug candidates for the treatment of patients with various cancers in the Mainland China.
1244
HK$4.18
7D
42.7%
1Y
-38.7%
ImmuneOnco Biopharmaceuticals (Shanghai)
Market Cap: HK$1.9b
A biotechnology company, engages in the research and development of immuno-oncology therapies in the People’s Republic of China.
1541
HK$4.57
7D
-7.5%
1Y
-73.1%
Sana Biotechnology
Market Cap: US$654.2m
A biotechnology company, focuses on utilizing engineered cells as medicines.
SANA
US$2.77
7D
9.9%
1Y
-68.9%
Matricelf
Market Cap: ₪55.8m
A biotechnology company, develops a platform for autologous tissue engineering for various medical conditions.
MTLF
₪3.46
7D
0.2%
1Y
-30.9%
Adlai Nortye
Market Cap: US$84.1m
A clinical-stage biotechnology company, focuses on the discovery and development of cancer therapies in the United States and Mainland China.
ANL
US$2.25
7D
-3.4%
1Y
-75.1%
GlycoMimetics
Market Cap: US$17.0m
Engages in the discovery and development of therapies for cancers and inflammatory diseases in the United States.
GLYC
US$0.27
7D
3.2%
1Y
-90.4%
Starpharma Holdings
Market Cap: AU$41.2m
A biopharmaceutical company, engages in the research, development, and commercialization of dendrimer products for pharmaceutical, life science, and other applications worldwide.
SPL
AU$0.10
7D
-4.8%
1Y
-20.0%
Sona Nanotech
Market Cap: CA$34.3m
Operates as a nanotechnology life sciences company.
SONA
CA$0.30
7D
0%
1Y
-31.8%
Avicanna
Market Cap: CA$38.6m
A commercial-stage biopharmaceutical company, engages in the research, development, advancement, and commercialization of evidence-based cannabinoid-based products and formulations for consumer, medical, and pharmaceutical markets worldwide.
AVCN
CA$0.35
7D
-5.3%
1Y
-37.7%
Elite Pharmaceuticals
Market Cap: US$513.8m
A specialty pharmaceutical company, engages in the development, manufacture, and sale of oral, controlled-release products, and generic pharmaceuticals.
ELTP
US$0.48
7D
0.2%
1Y
236.8%
Lionco Pharmaceutical GroupLtd
Market Cap: CN¥3.4b
Lionco Pharmaceutical Group Co., Ltd., together with its subsidiaries, researches, develops, produces, and sells pharmaceuticals in China.
603669
CN¥4.85
7D
1.0%
1Y
9.5%
Lepu Biopharma
Market Cap: HK$5.5b
A biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for cancer targeted therapy and immunotherapy in China and internationally.
2157
HK$3.20
7D
-2.1%
1Y
-2.1%